Because EPA is the precursor to DHA and therefore responsible for the in vivo formation of DHA there should be no risks involved with taking EPA long term. Indeed, The Japan eicosapentaenoic acid (EPA) Lipid Intervention Study (JELIS) is a clinical trial in which indivduals have been taking EPA 1800 mg/day for a period of 5 years with no adverse affects.
I would like to confirm the group order list are Available for 18 boxes for our the name list as belows.)
Pls kindly check your PM that Vegepa MUST request rcv payment then they will arrange delivery accordingly. So, pls kindly arrange transfer accordingly latest on this weekend (21/03/09).